Biomarker-guided targeted therapy in platinum-resistant ovarian cancer (AMBITION; KGOG 3045): a multicentre, open-label, five-arm, uncontrolled, umbrella trial.

Published in: Journal of gynecologic oncology (2022)

ClinicalTrials.gov Identifier: NCT03699449.

Keyphrases